[Federal Register Volume 85, Number 60 (Friday, March 27, 2020)]
[Notices]
[Page 17334]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06367]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee (LEPAC); Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Lead Exposure and Prevention 
Advisory Committee (LEPAC). This meeting is open to the public by web 
conference; however, advance registration is needed by April 15, 2020, 
to receive the information to join the meeting. The registration link 
is https://rossstrategic.zoom.us/webinar/register/WN_I76JZ04RT5SVinnqu_tSYw. The public comment period is scheduled on 
April 29, 2020, from 1:45 p.m. until 2:00 p.m., EDT. Individuals 
wishing to make a comment during the public comment period, please 
email your name, organization, and phone number by April 15, 2020, to 
[email protected].

DATES: The meeting will be held on April 29, 2020, from 9:00 a.m. to 
4:30 p.m., EDT.

ADDRESSES:  To receive web conference access please register at https://rossstrategic.zoom.us/webinar/register/WN_I76JZ04RT5SVinnqu_tSYw by 
April 15, 2020.

FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated 
Federal Officer, National Center for Environmental Health, CDC, 4770 
Buford Highway, Atlanta, GA 30341, 770-488-3300; email address: 
[email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The Lead Exposure and Prevention Advisory Committee was 
established under Section 2203 of Public Law 114-322, the Water 
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27, 
Registry for Lead Exposure and Advisory Committee.
    The Secretary, Department of Health and Human Services (HHS) and by 
delegation, the Director, CDC and Administrator, NCEH/ATSDR, are 
authorized under Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27) 
to review research and Federal programs and services related to lead 
poisoning and to identify effective services and best practices for 
addressing and preventing lead exposure in communities.
    The LEPAC is charged with providing advice and guidance to the 
Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on the: 
(1) Review of Federal programs and services available to individual 
communities exposed to lead; (2) review current research on lead 
exposure to identify additional research needs; (3) review and identify 
best practices, or the need for best practices regarding lead screening 
and the prevention of lead poisoning; (4) identify effective services, 
including services relating to healthcare, education, and nutrition for 
individuals and communities affected by lead exposure and lead 
poisoning, including in consultation with, as appropriate, the lead 
exposure registry as established in Section 2203(b) of Public Law 114-
322; and (5) undertake any other review or activities that the 
Secretary determines to be appropriate.
    Matters To Be Considered: The agenda will include: Discussions on 
CDC's role in lead poisoning prevention, key federal lead programs and 
the Federal Lead Action Plan, methods and results of a Community Guide 
environmental scan and scoping review of lead interventions, lessons 
learned from review of CDC Childhood Lead Poisoning Prevention Program 
(CLPPP) cooperative agreement recipients, and available services and 
best practices regarding lead screening and the prevention of lead 
poisoning. Agenda items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-06367 Filed 3-26-20; 8:45 am]
 BILLING CODE 4163-18-P